Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials
- 28 July 2008
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 6 (11) , 1243-1248
- https://doi.org/10.1016/j.cgh.2008.07.013
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology, 2006
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2006
- Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitisLiver International, 2006
- Yo Jyo Hen Shi Ko (YHK) Improves Transaminases in Nonalcoholic Steatohepatitis (NASH): A Randomized Pilot StudyDigestive Diseases and Sciences, 2006
- A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trialHepatology, 2004
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Hepatology, 2004
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- Asymptotic Optimality of Fisher's Method of Combining Independent TestsJournal of the American Statistical Association, 1971